DPYD and Hand-foot syndrome: Most (> 85%) administered 5-FU is degraded by the enzyme dihydropyrimidine dehydrogenase (DPD) in the liver, generating alpha-fluoro-beta-alanine (FBAL) [2], a catabolite associated with off-target toxicities such as hand-foot syndrome and cardiotoxicity [3–5].